Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21854)

• Formulation Name: Valproic acid 125 mg tablet
• Company: NCS HealthCare of KY, Inc dba Vangard Labs; RemedyRepack; Unichem Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Valproate	(DMCFE9I)	Epilepsy	8A60-8A68	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Butyl alcohol	(E00011)	263	Flavoring agent; Solvent
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Isopropyl alcohol	(E00070)	3776	Antimicrobial preservative; Solvent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium bicarbonate	(E00424)	516892	Alkalizing agent; Diluent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent
Vanillin	(E00049)	1183	Flavoring agent